The Journal of Molecular Diagnostics

The official publication of the Association for Molecular Pathology @AMPath, co-owned by the American Society for Investigative Pathology @ASIPath.

[The Journal of Molecular Diagnostics @JMDiagn]

@JMDiagn: Advancing Genomic Medicine and Informatics

Submit your #moldx #molpath and #bioinformatics advancements today- submission is free!

https://t.co/of5UuvRf1f

#hemepath #genetics #infectiousdisease #solidtumors #informatics

[The Journal of Molecular Diagnostics @JMDiagn]

Read the latest Guest Editorial in The Journal of Molecular Diagnostics: Optimization of Pathologists' Roles in Molecular Biomarker Testing in Metastatic Breast Cancer: A Consensus Statement.

Full text: https://t.co/xw8PsjytDu

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Clinical Bioinformatician Body of Knowledge—Bioinformatics and Software Core: A Report of the @AMPath.

Read for free: https://t.co/p0V5wavzjk

[Elsevier News @ElsevierNews]

RNA-based testing uncovers extraordinary diversity in genomic alterations leading to MET exon 14 skipping in #NSCLC patients. Novel approach detailed in @JMDiagn can improve diagnostics and inform targeted treatment for lung cancer. https://t.co/pFD13vOTyj
@ASIPath
@AMPath

[The Journal of Molecular Diagnostics @JMDiagn]

Read the Body of Knowledge papers in the July 2025 issue of JMD- all for free!

https://t.co/d3ef28GZV8

[Association for Molecular Pathology @AMPath]

Join the 1st broadcast in our Body of Knowledge series Aug. 12. Based on the @JMDiagn papers of the same name, this session explores the key role of bioinformaticians in molecular diagnostic labs through insights from the project's steering committee.

https://t.co/AR90H6Juli

[Association for Molecular Pathology @AMPath]

We will be hosting a series of broadcasts about essential bioinformatics roles, responsibilities and competencies for professionals in clinical molecular diagnostic laboratories, based on a 2025 collection of papers published in @JMDiagn.

Learn more: https://t.co/kjQibdJgo3

[Association for Molecular Pathology @AMPath]

Whether you’re interested in inherited disorders or molecular predictors used in precision medicine, the @JMDiagn genetics section offers insights into cutting-edge diagnostic approaches, variant interpretation and genetic test design.

See what’s new: 👉 https://t.co/deFWwVK4PU

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Analytical Validation and Clinical Sensitivity of the Belay Summit assay for the detection of DNA variants in cerebrospinal fluid of primary and metastatic CNS cancer. From @AMPath member Dr. Honey Reddi and colleagues.

#OpenAccess text: https://t.co/ZtHlVaJM4n

[Association for Molecular Pathology @AMPath]

@JMDiagn is seeking manuscripts on molecular diagnostics for infectious diseases, including assay development, validation, resistance detection and metagenomic approaches with clear clinical relevance.

Submit your work here: https://t.co/PLTbZGB0Au

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Read the #PracticeAdvance from @AMPath: "Catching Up to Increased Complexity in Breast Cancer Molecular Testing". Authors from @StanfordPath (@Stanford), @WashU and @AstraZeneca.

https://t.co/xnaefpB5Oy

[The Journal of Molecular Diagnostics @JMDiagn]

#ArticleinPress: Genetic Landscape of Acute Leukemia of Ambiguous Lineage: A Single Cancer Center Experience. Authors from @cityofhope.

Full text: https://t.co/I1sD1dGuti

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Clinical Bioinformatician Body of Knowledge – Molecular Diagnostics Core: A Report of the @AMPath. Authors from @FabricGenomics, @bswhealth, @PathGroupLabs, @bcmhouston, @StanfordMed and @ARUPLabs.

Full text: https://t.co/rMEh4hmlWh

[The Journal of Molecular Diagnostics @JMDiagn]

Rapid On-Site Next-Generation Sequencing: An Alternative to Single-Gene and Send-Out Testing in NSCLC and Colorectal Cancer in a Community Pathology Laboratory Setting. From @AMPath member Ossama Tawfik and colleagues at @saintlukeskc.

https://t.co/B0FDS6BJAt

[Association for Molecular Pathology @AMPath]

In @JMDiagn, discover research that’s shaping how clinicians detect and treat cancer at the molecular level. Explore the latest in molecular diagnostics for solid tumors here:

https://t.co/ZMc698Smmb

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Development of a Body of Knowledge for the Clinical Bioinformatician: Perspectives from the @AMPath's Clinical Genomics Bioinformatician Body of Knowledge Steering Committee

Full text: https://t.co/twSfpGIXf3

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: A New Era for Molecular Diagnostics: Reclaiming Strategic Vision for Patient Care.

Full Guest Editorial: https://t.co/LzhyEkDCRZ

[The Journal of Molecular Diagnostics @JMDiagn]

The deadline for abstract submission to #AMP2026
is today at midnight!

Abstracts will be published in @JMDiagn as an online supplement. Get yours submitted before it's too late!

[Association for Molecular Pathology @AMPath]

TODAY (6/30) is the deadline to submit an abstract for #AMP2026 in Seattle!

Submit here for FREE: https://t.co/aIMVX6lpiv

If you have any trouble, email us at [email protected].

Best of luck, and we look forward to reading about the important work you've been doing!

[Association for Molecular Pathology @AMPath]

👨‍🏫 @JMDiagn welcomes papers focused on translating and validating molecular discoveries and advancing technologies for clinical diagnostics.

Submit your work today: https://t.co/PLTbZGB0Au

[The Journal of Molecular Diagnostics @JMDiagn]

Read the new Guest Editorial coming out soon in The Journal of Molecular Diagnostics: Optimization of Pathologists' Roles in Molecular Biomarker Testing in Metastatic Breast Cancer

Full text: https://t.co/xw8PsjytDu

[The Journal of Molecular Diagnostics @JMDiagn]

#ArticleinPress: Digital PCR for Absolute Quantification of Adenoviruses. From @AMPath member Dr. Heba Mostafa and colleagues from @HopkinsMedicine.

#OpenAccess text: https://t.co/PE47M4YbbA

[The Journal of Molecular Diagnostics @JMDiagn]

#LegacyContent: Rapid screening and monitoring of UBA1 mutations in VEXAS syndrome. Authors from @GVAclinic, @HospitalLaFe, @incliva_iis and @UV_EG.

Free in the #OpenArchive: https://t.co/ZlduzDlOhD